Back to News
Market Impact: 0.4

Truist cuts Trade Desk stock rating on macro and execution issues

Corporate EarningsCorporate Guidance & OutlookAnalyst EstimatesCompany Fundamentals
Truist cuts Trade Desk stock rating on macro and execution issues

Truist downgraded The Trade Desk (TTD) to Hold and cut its price target to $16 from $35 as the stock trades near a 52-week low (~$16.70) and is down ~80% YoY. Q2 showed a mixed setup with adjusted EPS of $0.34 beating $0.18, but revenue missed at $715M vs $752.6M and Q3 guidance came in below consensus amid macro/tariff headwinds and execution issues tied to management turnover. The firm expects the turnaround to take several quarters, reinforcing cautious market positioning as multiple brokerages lowered targets.

Analysis

TTD is in the classic "multiple de-rating first, fundamental repair later" phase: once a platform loses operating momentum, the market stops paying for secular growth and starts pricing execution risk like a cyclical ad-tech name. The next leg is less about one quarter and more about whether management can show budget retention from large brand/CPG clients before revenue compounding stalls for multiple quarters. If that repair takes 2-3 quarters, the equity can remain range-bound even if the balance sheet is fine.

The competitive issue is that in periods of tariff/geopolitical stress, advertisers usually consolidate spend into channels with clearer ROI and stronger first-party data. That mechanically favors GOOG, META, and AMZN over open-web DSPs, while smaller publishers and independent ad tech can see a larger share of wallet leak away as brands cut experimental spend first. If CPG budgets stay pressured, the second-order effect is not just lower TTD growth; it is a structural mix shift toward walled gardens that can outlast the macro noise.

Contrarianly, the stock may already be discounting a lot of this: after an ~80% drawdown, a lot of the "bad leadership + weak macro" story is embedded, and any stabilization in guidance could trigger a sharp relief rally from oversold positioning. The real falsifier for the bearish thesis is not a single beat, but 1) sequential reacceleration in billings/revenue within the next 1-2 quarters, 2) evidence that client churn is not worsening, and 3) a return of CPG spending once tariff visibility improves. If those do not show up, the risk is that the market keeps compressing the multiple even if absolute EBITDA remains positive.

More News